GHRYVELIN (previously Macimorelin Aeterna Zentaris) الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

ghryvelin (previously macimorelin aeterna zentaris)

atnahs pharma netherlands b.v. - macimorelin myndir - greiningaraðferðir, annarra - macimorelin - Þetta lyf er eingöngu ætlað til greiningar.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Kenacort-T Stungulyf, dreifa 40 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

kenacort-t stungulyf, dreifa 40 mg/ml

bristol-myers squibb ab - triamcinolonum acetóníð - stungulyf, dreifa - 40 mg/ml

Protopic الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrólímus - dermatitis, atópísk - aðrar húðsjúkdómar - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. koma fjórir eða meira sinnum á ári) sem hafa haft fyrstu viðbrögð við sex vikur meðferð tvisvar á dag takrólímus smyrslið (sár ruddi, næstum ruddi eða dálítið áhrifum).